SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 291 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $461,000 | +12.2% | 13,145 | +6.2% | 0.02% | -5.0% |
| Q4 2018 | $411,000 | -31.8% | 12,377 | +3.4% | 0.02% | -20.0% |
| Q3 2018 | $603,000 | -68.7% | 11,968 | -62.8% | 0.02% | -73.1% |
| Q2 2018 | $1,924,000 | +281.7% | 32,152 | +191.9% | 0.09% | +615.4% |
| Q1 2018 | $504,000 | +20.0% | 11,015 | +4.5% | 0.01% | +62.5% |
| Q4 2017 | $420,000 | -5.0% | 10,536 | -4.6% | 0.01% | -11.1% |
| Q3 2017 | $442,000 | -5.8% | 11,044 | +1.6% | 0.01% | -10.0% |
| Q2 2017 | $469,000 | – | 10,872 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 699,432 | $35,216,000 | 4.25% |
| Provident Investment Management, Inc. | 590,269 | $29,720,000 | 4.23% |
| CAPITAL MANAGEMENT CORP /VA | 225,232 | $11,340,000 | 2.90% |
| FALCON POINT CAPITAL, LLC | 188,341 | $9,483,000 | 2.04% |
| Ranger Investment Management | 600,464 | $30,233,000 | 2.00% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 471,260 | $23,728,000 | 1.96% |
| KOPP INVESTMENT ADVISORS LLC | 41,700 | $2,100,000 | 1.77% |
| SHAKER INVESTMENTS LLC/OH | 49,617 | $2,498,000 | 1.54% |
| Bruce & Co., Inc. | 148,058 | $7,454,000 | 1.44% |
| Bridge City Capital, LLC | 45,843 | $2,308,000 | 1.43% |